Virax Biolabs Group (VRAX) Q1 2024 Earnings
VRAX·Reported August 20, 2024·Before market open
Virax Biolabs Group reported Q1 2024 revenue of $79.9K, missed analyst consensus of $1.0M by $920.1K. Diluted EPS came in at $-1.71.
Revenue
$79.9Kmissed by $920.1K
Consensus: $1.0MDiluted EPS
$-1.71
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2024 Earnings FAQ
Common questions about Virax Biolabs Group's Q1 2024 earnings report.
Virax Biolabs Group (VRAX) reported Q1 2024 earnings on August 20, 2024 before market open.
Virax Biolabs Group reported revenue of $79.9K and diluted EPS of $-1.71 for Q1 2024.
Revenue missed the consensus estimate of $1.0M by $920.1K.